EuroEyes International Eye Clinic logo

EuroEyes International Eye Clinic(SEHK) 1846

Market CapHK$816.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-75%
5 Year-76%
1 Year-20%
1 Month+9%
HK$2.50
-1.96%
-0.05Today
EuroEyes International Eye Clinic last closing stock price
MetricPriceDate
Last closeHKD 2.502026-10-15
EuroEyes International Eye Clinic stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.79%HKD 2.522026-10-08
1 month+8.7%HKD 2.302026-09-15
3 month+0.81%HKD 2.482026-07-17
Year to date-17.76%HKD 3.042025-12-31
1 year-19.61%HKD 3.112025-10-15
3 year-44.81%HKD 4.532023-10-16
5 year-75.73%HKD 10.302021-10-15
Since inception-74.81%HKD 10.122019-10-15

EuroEyes International Eye Clinic Financials at a Glance

Market Cap

HK$816.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$1.60B

Net Income (TTM)

HK$79.02M

EPS (TTM)

HK$0.01

P/E Ratio

331.17

Dividend

HK$0.01

Beta (Volatility)

-0.08 (Low)

Price

HK$2.50

Volume

11,000

Open

HK$2.50

Previous Close

HK$2.55

Daily Range

HK$2.50 - HK$2.50

52-Week Range

HK$2.30 - HK$3.35

Estimated Earnings Date

Mar 31, 2027

1846 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EuroEyes International Eye Clinic

EuroEyes International Eye Clinic Limited specializes in vision correction services across Germany, China, Denmark, and the UK. The company offers a range of advanced laser eye surgeries and related services, positioning itself as a leader in the medical care facilities industry.

Products and Services
  • Laser eye surgery options including SMILE Pro and Femto-Lasik
  • Lens exchange surgery with monofocal and trifocal options
  • Consultation centers and training services for eye treatment
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increasing demand for vision correction services supports long-term profitability
  • Technological advancements in eye care enhance service offerings
Financial Highlights
  • Recent quarterly revenue of 454.33 million HKD shows a strong upward trend
  • Trailing twelve months (TTM) gross profit margin stands at 38.03%
  • Cash and cash equivalents reached 607.70 million HKD, indicating solid liquidity
EuroEyes International Eye Clinic Limited has established a robust presence in the eye care sector, offering a variety of innovative surgical options. The company's strategic focus on expanding its market reach and enhancing service quality positions it well for future growth. Recent financial performance indicates a positive trajectory, with significant revenue generation and a healthy gross profit margin. The liquidity position is strong, providing a solid foundation for ongoing operations and potential investments in technology and infrastructure. Overall, EuroEyes presents an intriguing opportunity within the healthcare industry, particularly for those interested in the evolving landscape of vision correction services.
AI Generated • Oct 1, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

404

CEO

Jørn Slot Jørgensen, MD

Website

www.euroeyes.hk

Headquarters

Hamburg, CQ 20355, DE

1846 Financials

Key Financial Metrics (TTM)

Gross Margin

38.03%

Operating Margin

5.46%

Net Income Margin

0.28%

Return on Equity

0.20%

Return on Capital

6.91%

Return on Assets

0.14%

Earnings Yield

0.30%

Dividend Yield

0.49%

Payout Ratio

4.06%

Stock Overview

Market Cap

HK$816.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

320.30M

Volume

11.00K

Avg. Volume

19.10K

Financials (TTM)

Gross Profit

HK$627.53M

Operating Income

HK$170.28M

EBITDA

HK$423.26M

Operating Cash Flow

HK$379.52M

Capital Expenditure

-HK$109.37M

Free Cash Flow

HK$270.15M

Cash & ST Invst.

HK$607.70M

Total Debt

HK$387.47M

EuroEyes International Eye Clinic Performance Analysis

EuroEyes International Eye Clinic annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 610,291,000-3.6%
20232023-12-31HKD 714,289,00017.0%
20242024-12-31HKD 715,682,0000.2%
20252025-12-31HKD 796,041,00011.2%
EuroEyes International Eye Clinic sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-5.7%
Q22025-06-308.6%
Q42025-12-3111.1%
Q22026-06-308.5%
EuroEyes International Eye Clinic annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.27-33.6%
20232023-12-31HKD 0.4046.7%
20242024-12-31HKD 0.25-36.9%
20252025-12-31HKD 0.17-31.6%
EuroEyes International Eye Clinic sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-7.7%
Q22025-06-30N/A
Q42025-12-31-58.2%
Q22026-06-30-184.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$454.33M

+23.3%

Gross Profit

HK$164.62M

+11.2%

Gross Margin

36.23%

N/A

Market Cap

HK$816.77MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$2.02M

N/A

Employees

404

N/A

Net Income

-HK$13.56M

-130.7%

EBITDA

HK$80.35M

-32.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$607.70M

-14.7%

Total Debt

HK$387.47M

+10.6%

Accounts Receivable

HK$16.73M

+55.1%

Inventory

HK$17.30M

-38.8%

Long Term Debt

HK$309.63M

+9.9%

Short Term Debt

HK$77.84M

+13.6%

Return on Assets

0.14%

N/A

Return on Invested Capital

2.97%

N/A

Free Cash Flow

HK$60.85M

+8.2%

Operating Cash Flow

HK$91.02M

-11.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$42.52+13.63%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.12-5.95%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$36.00+5.93%

Questions About 1846

What is the current price of EuroEyes International Eye Clinic?

EuroEyes International Eye Clinic is trading at HK$2.50 per share.

What is the 52-week range for EuroEyes International Eye Clinic?

Over the past 52 weeks, EuroEyes International Eye Clinic has traded between HK$2.30 and HK$3.35.

How much debt does EuroEyes International Eye Clinic have?

As of the most recent reporting period, EuroEyes International Eye Clinic reported total debt of HK$410.19M.

How much cash does EuroEyes International Eye Clinic have on hand?

EuroEyes International Eye Clinic reported HK$696.70M in cash and cash equivalents in its most recent financial results.

What is EuroEyes International Eye Clinic’s dividend yield?

EuroEyes International Eye Clinic currently has a dividend yield of 0.49%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services